How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

The latest sign that ending the conflict will be messy and take longer than expected came on Sunday, when Iran and Israel resumed fighting. Unsurprisingly, oil prices spiked, rising 4% in early Monday ...

Disney is experiencing renewed optimism from analysts on the back of sustained strong performance in its theme parks. While there are certain short-term tailwinds, the long-term picture for the stock ...

Unsafe AI systems are leading to cyber weapons of mass destruction Stuart Russell is a computer scientist known for his contributions to AI and a new Guardian US columnist The AI company Anthropic has ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

Your institution does not have access to this book on JSTOR. Try searching on JSTOR for other items related to this book. https://doi.org/10.2307/j.ctvjnrt76.5 https ...

Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Lea Uradu, J.D., is a Maryland state registered tax preparer, state-certified notary public, ...